Eutilex Competitors and Similar CompaniesClear all
Eutilex's competitors and similar companies include Zymeworks, JW Therapeutics, Neovii and ImmPACT-Bio.
 Eutilex Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology. |  Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. |  Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
|  ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. | ||
Founding Date | Founding Date 2015 | Founding Date 2003 | Founding Date 2016 | Founding Date 2003 | Founding Date 2017 |
Type | Type Public | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations KR HQ | Locations Vancouver, CA HQ Seattle, US | Locations CN HQ Suzhou Shi, CN | Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US | Locations Camarillo, US HQ Rishon Le Tsiyon, IL |
Employees | Employees 141 | Employees 45519% increase | Employees 106 | Employees 1111% increase | Employees 1082% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) ₩131.7m (FY, 2023) | Revenue (est.) $76m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income (₩28.3b) (FY, 2023) | Net income ($118.7m) (FY, 2023) | Net income N/A | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 90m (almost 7 years ago) | Latest funding round N/A | Latest funding round $ 18m (over 4 years ago) |
Total funding raised | Total funding raised $ 18.9m | Total funding raised $ 125.9m | Total funding raised $ 90m | Total funding raised N/A | Total funding raised $ 18m |
For sources of this data, please see the company profile
View Company Profiles
Zymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
View company
JW Therapeutics
HQ
CN
Employees
106
JW Therapeutics is a biotech company focusing on clinical cell therapy technology.
View companyNeovii
HQ
Rapperswil-Jona, CH
Employees
111↑ 1% increase
Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
View companyImmPACT-Bio
HQ
Camarillo, US
Employees
108↑ 2% increase
ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.
View company